Ligand profile
KC7
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_01981 — Chaperone protein dnaK
Identifiers
Database identifiers and provenance.
- Ligand ID
KC7- PDB
5aqx- UniProt (similar protein)
P0DMV8- Target protein
- KP13_01981
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 107.7
- −1 ≤ LogP ≤ 5 1.72
- MW ≤ 500 Da 381.4
- LogP ≤ 5 1.72
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 107.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1ccc(cc1)COc2cccc3c2c(ncn3)N[C@@H]4C[C@@H]([C@H]([C@H]4O)O)COc1ccc(cc1)COc2cccc3c2c(ncn3)N[C@@H]4C[C@@H]([C@H]([C@H]4O)O)CO
InChI=1S/C21H23N3O4/c25-10-14-9-16(20(27)19(14)26)24-21-18-15(22-12-23-21)7-4-8-17(18)28-11-13-5-2-1-3-6-13/h1-8,12,14,16,19-20,25-27H,9-11H2,(H,22,23,24)/t14-,16-,19-,20+/m1/s1InChI=1S/C21H23N3O4/c25-10-14-9-16(20(27)19(14)26)24-21-18-15(22-12-23-21)7-4-8-17(18)28-11-13-5-2-1-3-6-13/h1-8,12,14,16,19-20,25-27H,9-11H2,(H,22,23,24)/t14-,16-,19-,20+/m1/s1
CFXPBFZKXXQRCM-FCNFAXOHSA-NCFXPBFZKXXQRCM-FCNFAXOHSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00012
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand KC7 →
- PDB RCSB structure 5aqx →
- UniProt UniProt P0DMV8 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “KC7”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_01981.
PDB 19
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).